158 related articles for article (PubMed ID: 19224168)
1. Costimulatory molecule B7-H1 on the immune escape of bladder cancer and its clinical significance.
Wang Y; Zhuang Q; Zhou S; Hu Z; Lan R
J Huazhong Univ Sci Technolog Med Sci; 2009 Feb; 29(1):77-9. PubMed ID: 19224168
[TBL] [Abstract][Full Text] [Related]
2. Effect of TLR4 and B7-H1 on immune escape of urothelial bladder cancer and its clinical significance.
Wang YH; Cao YW; Yang XC; Niu HT; Sun LJ; Wang XS; Liu J
Asian Pac J Cancer Prev; 2014; 15(3):1321-6. PubMed ID: 24606459
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers.
Nakanishi J; Wada Y; Matsumoto K; Azuma M; Kikuchi K; Ueda S
Cancer Immunol Immunother; 2007 Aug; 56(8):1173-82. PubMed ID: 17186290
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of B7-H1 and B7-1 expressions in pancreatic carcinoma.
Wang L; Ma Q; Chen X; Guo K; Li J; Zhang M
World J Surg; 2010 May; 34(5):1059-65. PubMed ID: 20145927
[TBL] [Abstract][Full Text] [Related]
5. Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance.
Geng Y; Wang H; Lu C; Li Q; Xu B; Jiang J; Wu C
Int J Clin Oncol; 2015 Apr; 20(2):273-81. PubMed ID: 24804867
[TBL] [Abstract][Full Text] [Related]
6. Association between B7-H1 expression and bladder cancer: a meta-analysis.
Wang YU; Liu AN; Zhao SH
Genet Mol Res; 2015 Feb; 14(1):1277-86. PubMed ID: 25730066
[TBL] [Abstract][Full Text] [Related]
7. Correlation between messenger RNA expression and protein expression of immune checkpoint-associated molecules in bladder urothelial carcinoma: A retrospective study.
Le Goux C; Damotte D; Vacher S; Sibony M; Delongchamps NB; Schnitzler A; Terris B; Zerbib M; Bieche I; Pignot G
Urol Oncol; 2017 May; 35(5):257-263. PubMed ID: 28291636
[TBL] [Abstract][Full Text] [Related]
8. T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival.
Boorjian SA; Sheinin Y; Crispen PL; Farmer SA; Lohse CM; Kuntz SM; Leibovich BC; Kwon ED; Frank I
Clin Cancer Res; 2008 Aug; 14(15):4800-8. PubMed ID: 18676751
[TBL] [Abstract][Full Text] [Related]
9. A fiber-modified adenoviral vector interacts with immunoevasion molecules of the B7 family at the surface of murine leukemia cells derived from dormant tumors.
Grellier E; Lécolle K; Rogée S; Couturier C; D'Halluin JC; Hong SS; Fender P; Boulanger P; Quesnel B; Colin M
Mol Cancer; 2011 Aug; 10():105. PubMed ID: 21884581
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.
Dong H; Strome SE; Salomao DR; Tamura H; Hirano F; Flies DB; Roche PC; Lu J; Zhu G; Tamada K; Lennon VA; Celis E; Chen L
Nat Med; 2002 Aug; 8(8):793-800. PubMed ID: 12091876
[TBL] [Abstract][Full Text] [Related]
11. The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors.
Ghebeh H; Mohammed S; Al-Omair A; Qattan A; Lehe C; Al-Qudaihi G; Elkum N; Alshabanah M; Bin Amer S; Tulbah A; Ajarim D; Al-Tweigeri T; Dermime S
Neoplasia; 2006 Mar; 8(3):190-8. PubMed ID: 16611412
[TBL] [Abstract][Full Text] [Related]
12. [Expression of B7-H1 protein in human pancreatic carcinoma tissues and its clinical significance].
Chen XL; Yuan SX; Chen C; Mao YX; Xu G; Wang XY
Ai Zheng; 2009 Dec; 28(12):1328-32. PubMed ID: 19958630
[TBL] [Abstract][Full Text] [Related]
13. Significance of B7-H1 overexpression in kidney cancer.
Thompson RH; Kwon ED
Clin Genitourin Cancer; 2006 Dec; 5(3):206-11. PubMed ID: 17239274
[TBL] [Abstract][Full Text] [Related]
14. FOXP3+ Tregs and B7-H1+/PD-1+ T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy.
Ghebeh H; Barhoush E; Tulbah A; Elkum N; Al-Tweigeri T; Dermime S
BMC Cancer; 2008 Feb; 8():57. PubMed ID: 18294387
[TBL] [Abstract][Full Text] [Related]
15. Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target.
Thompson RH; Gillett MD; Cheville JC; Lohse CM; Dong H; Webster WS; Krejci KG; Lobo JR; Sengupta S; Chen L; Zincke H; Blute ML; Strome SE; Leibovich BC; Kwon ED
Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17174-9. PubMed ID: 15569934
[TBL] [Abstract][Full Text] [Related]
16. Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model.
Okudaira K; Hokari R; Tsuzuki Y; Okada Y; Komoto S; Watanabe C; Kurihara C; Kawaguchi A; Nagao S; Azuma M; Yagita H; Miura S
Int J Oncol; 2009 Oct; 35(4):741-9. PubMed ID: 19724910
[TBL] [Abstract][Full Text] [Related]
17. Interaction of B7-H1 on intrahepatic cholangiocarcinoma cells with PD-1 on tumor-infiltrating T cells as a mechanism of immune evasion.
Ye Y; Zhou L; Xie X; Jiang G; Xie H; Zheng S
J Surg Oncol; 2009 Nov; 100(6):500-4. PubMed ID: 19697355
[TBL] [Abstract][Full Text] [Related]
18. Immunology of B7-H1 and its roles in human diseases.
Tamura H; Ogata K; Dong H; Chen L
Int J Hematol; 2003 Nov; 78(4):321-8. PubMed ID: 14686489
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of B7-H1 (PD-L1) expression in human acute leukemia.
Chen X; Liu S; Wang L; Zhang W; Ji Y; Ma X
Cancer Biol Ther; 2008 May; 7(5):622-7. PubMed ID: 18756622
[TBL] [Abstract][Full Text] [Related]
20. Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the bladder.
Xylinas E; Robinson BD; Kluth LA; Volkmer BG; Hautmann R; Küfer R; Zerbib M; Kwon E; Thompson RH; Boorjian SA; Shariat SF
Eur J Surg Oncol; 2014 Jan; 40(1):121-7. PubMed ID: 24140000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
